Effect of simvastatin on expression of transforming growth factor-β and collagen type IV in rat mesangial cells

Pharmacology

Volumn 88, Issue 3-4, 2011, Pages 188-192

  Li, Yan Bo ^a   Yin, Jia Jing ^a   Wang, Hong Jie ^a   Wang, Jun ^a   Tian, Hui ^a   Yang, Min ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Collagen type IV; Diabetic nephropathy; Mesangial cells, rat; p38 mitogen activated protein kinase; Simvastatin; Transforming growth factor

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADVANCED GLYCATION END PRODUCT; COLLAGEN TYPE 4; GLUCOSE; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; SIMVASTATIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; CELLS, CULTURED; COLLAGEN TYPE IV; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HYDROGEN PEROXIDE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMIDAZOLES; MESANGIAL CELLS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; PYRIDINES; RATS; SIMVASTATIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 80155172504     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000330739     Document Type: Article

References (27)

1. Li YB, Han JY, Jiang W, Wang J: Selenium inhibits high glucose-induced cyclooxygenase-2. and P-selectin expression in vascular endothelial cells. Mol Biol Rep 2011; 38: 2301-2306.
2. Shikata K, Haneda M, Koya D, Suzuki Y, Tomino Y, Yamada K, Maeda S, Kawakami N, Uzu T, Nishimura M, Sato C, Ogawa D, Makino H: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): rationale and study design. Diabetes Res Clin Pract 2010; 87: 228-232.
3. Huang P, Zhang Y, Jiang T, Zeng W, Zhang N: Aldose reductase is a potent regulator of TGF-1-induced expression of fibronectin in human mesangial cells. Mol Biol Rep 2010; 37: 3097-3103.
4. Takaya K, Koya D, Isono M, Sugimoto T, Sugaya T, Kashiwagi A, Haneda M: Involvement of ERK pathway in albumin-induced MCP-1 expression in mouse proximal tubular cells. Am J Physiol Renal Physiol 2003; 284:F1037-F1045. (Pubitemid 36443589)
5. Stephan JP, Mao W, Filvaroff E, Cai L, Rabkin R, Pan G: Albumin stimulates the accumulation of extracellular matrix in renal tubular epithelial cells. Am J Nephrol 2004; 24: 14-19. (Pubitemid 38250482)
6. Vial C, Zuniga LM, Cabello-Verrugio C, Canon P, Fadic R, Brandan E: Skeletal muscle cells express the profibrotic cytokine connective tissue growth factor (CTGF/CCN2), which induces their dedifferentiation. J Cell Physiol 2008; 215: 410-421. (Pubitemid 351468953)
7. Alexander JJ, Zwingmann C, Jacob A, Quigg R: Alteration in kidney glucose and amino acids are implicated in renal pathology in MRL/lpr mice. Biochim Biophys Acta 2007; 1772: 1143-1149. (Pubitemid 350184272)
8. Ogawa K, Funaba M, Tsujimoto M: The effects of TGF-1 on the expression of type IV collagenases in mouse peritoneal macrophages. Mol Biol Rep 2011; 38: 1451-1456.
9. Nishihara K, Masuda S, Nakagawa S, Yonezawa A, Ichimura T, Bonventre JV, Inui K: Impact of cyclin B2 and cell division cycle 2 on tubular hyperplasia in progressive chronic renal failure rats. Am J Physiol Renal Physiol 2010; 298:F923-F934.
10. Luo DD, Phillips A, Fraser D: Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression. Am J Pathol 2010; 176: 1139-1147.
11. Tahara A, Tsukada J, Tomura Y, Suzuki T, Yatsu T, Shibasaki M: Vasopressin stimulates the production of extracellular matrix by cultured rat mesangial cells. Clin Exp Pharmacol Physiol 2008; 35: 586-593. (Pubitemid 351490096)
12. Tahara A, Tsukada J, Tomura Y, Yatsu T, Shibasaki M: Vasopressin increases type IV collagen production through the induction of transforming growth factor-secretion in rat mesangial cells. Pharmacol Res 2008; 57: 142-150.
13. Li C, Yang CW, Park JH, Lim SW, Sun BK, Jung JY, Kim SB, Kim YS, Kim J, Bang BK: Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy. Am J Physiol 2004; 286:F46-F57. (Pubitemid 38045041)
14. Najafian B, Mauer M: Progression of diabetic nephropathy in type 1 diabetic patients. Diabetes Res Clin Pract 2009; 83: 1-8.
15. Suzuki D, Miyazaki M, Jinde K, Koji T, Yagame M, Endoh M, Nomoto Y, Sakai H: In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1. and type IV collagen in diabetic nephropathy. Kidney Int 1997; 52: 111-119. (Pubitemid 27321821)
16. Sthaneshwar P, Chan SP: Urinary type IV collagen levels in diabetes mellitus. Malays J Pathol 2010; 32: 43-47.
17. Araki S, Haneda M, Koya D, Isshiki K, Kume S, Sugimoto T, Kawai H, Nishio Y, Kashiwagi A, Uzu T, Maegawa H: Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria. Diabetes Care 2010; 33: 1805-1810.
18. Liu Y, Wang Z, Yin W, Li Q, Cai M, Zhang C, Xiao J, Hou H, Li H, Zu X: Severe insulin resistance and moderate glomerulosclerosis in a minipig model induced by high-fat/highsucrose/high-cholesterol diet. Exp Anim 2007; 56: 11-20. (Pubitemid 46358577)
19. Niranjan T, Bielesz B, Gruenwald A, Ponda MP, Kopp JB, Thomas DB, Susztak K: The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 2008; 14: 290-298. (Pubitemid 351347919)
20. Zhou G, Li C, Cai L: Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor-independent pathway. Am J Pathol 2004; 165: 2033-2043. (Pubitemid 39578381)
21. Ohashi S, Abe H, Takahashi T, Yamamoto Y, Takeuchi M, Arai H, Nagata K, Kita T, Okamoto H, Yamamoto H, Doi T: Advanced glycation end products increase collagen-specific chaperone protein in mouse diabetic nephropathy. J Biol Chem 2004; 279: 19816-19823. (Pubitemid 38623421)
22. Chen S, Jim B, Ziyadeh FN: Diabetic nephropathy and transforming growth factor-: transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol 2003; 23: 532-543. (Pubitemid 38030087)
23. Vieira JM Jr, Mantovani E, Rodrigues LT, Delle H, Noronha IL, Fujihara CK, Zatz R: Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. Nephrol Dial Transplant 2005; 20: 1582-1591. (Pubitemid 41418580)
24. McCarey DW, Sattar N, McInnes IB: Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases? Arthritis Res Ther 2005; 7: 55-61. (Pubitemid 40439439)
25. Ou XM, Feng YL, Wen FQ, Huang XY, Xiao J, Wang K, Wang T: Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice. Chin Med J 2008; 121: 1821-1829.
26. Chen CC, Wang JK: p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages. Mol Pharmacol 1999; 55: 481-488.
27. Ortego M, Gómez-Hernández A, Vidal C, Sánchez- Galán E, Blanco-Colio LM, Martín-Ventura JL, Tuñón J, Diaz C, Hernández G, Egido J: HMG-CoA reductase inhibitors reduce IB kinase activity induced by oxidative stress in monocytes and vascular smooth muscle cells. J Cardiovasc Pharmacol 2005; 45: 468-475. (Pubitemid 40627967)